|
Orthologous residues
|
|
eNOS (human): S114‑p, eNOS (mouse): T113‑p, eNOS (rat): T113‑p, eNOS (rabbit): T120‑p, eNOS (pig): S116‑p, eNOS (cow): S116‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
BAEC (endothelial), COS (fibroblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
cow, monkey
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
VEGF
|
|
|
|
decrease
|
|
|
ATP
|
|
|
|
decrease
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
enzymatic activity, inhibited, molecular association, regulation, phosphorylation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
Akt1 (human)
|
|
Disrupts
|
|
|
co-immunoprecipitation, electrophoretic visualization
|
|
|
Comments:
eNOS S115A mutation increases phosphorylation of S1178 by about 50%
|